1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23265
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNakkam, Nontaya-
dc.contributor.authorGibson, Andrew-
dc.contributor.authorMouhtouris, Effie-
dc.contributor.authorKonvinse, Katherine-
dc.contributor.authorHolmes, Natasha E-
dc.contributor.authorChua, Kyra Y L-
dc.contributor.authorDeshpande, Pooja-
dc.contributor.authorLi, Danmeng-
dc.contributor.authorOstrov, David A-
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorPhillips, Elizabeth J-
dc.date2020-05-19-
dc.date.accessioned2020-05-25T05:23:33Z-
dc.date.available2020-05-25T05:23:33Z-
dc.date.issued2021-01-
dc.identifier.citationThe Journal of Allergy and Clinical Immunology 2021; 147(1): 403-405en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/23265-
dc.description.abstractAll fifteen patients with HLA-A*32:01 restricted vancomycin-induced DRESS, showed negative ex vivo responses to dalbavancin however two showed cross-reactivity to teicoplanin and telavancin. Adjunctive diagnostic testing should be considered to detect potential cross-reactivity amongst glycopeptides.en
dc.language.isoeng-
dc.subjectHLA-A*32:01en
dc.subjectVancomycin-induced DRESSen
dc.subjectcross-reactivityen
dc.subjectteicoplaninen
dc.subjecttelavancinen
dc.titleCross-reactivity between vancomycin, teicoplanin and telavancin in HLA-A*32:01 positive vancomycin DRESS patients sharing an HLA-Class II haplotype.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Journal of Allergy and Clinical Immunologyen
dc.identifier.affiliationInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, Australiaen
dc.identifier.affiliationDepartment of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; Vanderbilt University Medical Center, Nashville, USAen
dc.identifier.affiliationVanderbilt University Medical Center, Nashville, USAen
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, Gainesville, USAen
dc.identifier.affiliationDepartment of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationVanderbilt University Medical Center, Nashville, USAen
dc.identifier.affiliationSchool of Human Sciences, University of Western Australia, Western Australia, Australiaen
dc.identifier.affiliationInstitute for Immunology and Infectious Diseases, Murdoch University, Perth, Australiaen
dc.identifier.doi10.1016/j.jaci.2020.04.056en
dc.type.contentTexten
dc.identifier.orcid0000-0001-8501-4054en
dc.identifier.pubmedid32439433-
dc.type.austinJournal Article-
local.name.researcherChua, Kyra Y L
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
crisitem.author.deptMicrobiology-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

46
checked on Dec 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.